.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Chubb
US Army
Argus Health
Johnson and Johnson
Citi
QuintilesIMS
Federal Trade Commission
Teva
Mallinckrodt

Generated: June 23, 2017

DrugPatentWatch Database Preview

Vorapaxar sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for vorapaxar sulfate and what is the scope of vorapaxar sulfate patent protection?

Vorapaxar sulfate
is the generic ingredient in one branded drug marketed by Aralez Pharms and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Vorapaxar sulfate has one hundred and forty-nine patent family members in thirty-six countries.

Two suppliers are listed for this compound.

Summary for Generic Name: vorapaxar sulfate

Tradenames:1
Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Clinical Trials: see list647
Drug Prices:see low prices
DailyMed Link:vorapaxar sulfate at DailyMed

Pharmacology for Ingredient: vorapaxar sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aralez Pharms
ZONTIVITY
vorapaxar sulfate
TABLET;ORAL204886-001May 8, 2014RXYesYes7,235,567► SubscribeYY ► Subscribe
Aralez Pharms
ZONTIVITY
vorapaxar sulfate
TABLET;ORAL204886-001May 8, 2014RXYesYes► Subscribe► Subscribe
Aralez Pharms
ZONTIVITY
vorapaxar sulfate
TABLET;ORAL204886-001May 8, 2014RXYesYes7,304,078► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: vorapaxar sulfate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,713,999Thrombin receptor antagonists► Subscribe
6,645,987 Nor-seco himbacine derivatives useful as thrombin receptor antagonists► Subscribe
7,488,742Thrombin receptor antagonists► Subscribe
6,894,065 Thrombin receptor antagonists► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: vorapaxar sulfate

Country Document Number Estimated Expiration
South Africa200605550► Subscribe
Russian Federation2367660► Subscribe
South Korea101026929► Subscribe
Denmark1294714► Subscribe
Spain2297150► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: VORAPAXAR SULFATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0150025 00159Estonia► SubscribePRODUCT NAME: VORAPAKSAAR;REG NO/DATE: EU/1/14/976 21.01.2015
00746Netherlands► SubscribePRODUCT NAME: VORAPAXAR IN ELKE DOOR HET; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119
8 50011-2015Slovakia► SubscribePRODUCT NAME: VORAPAXARIUMSULFAT; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150121
0746Netherlands► SubscribePRODUCT NAME: VORAPAXAR, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT, IN HET BIJZONDER VORAPAXARSULFAAT; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150121
2015027Lithuania► SubscribePRODUCT NAME: VORAPAXARUM; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150119
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Mallinckrodt
Cantor Fitzgerald
Fish and Richardson
Julphar
Baxter
Harvard Business School
Moodys
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot